Neoadjuvant cemiplimab and surgery for stage II–IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00459-X/fulltext?dgcid=hubspot_email_conferencealerts_esmo23&utm_campaign=conferencealerts&utm_medium=email&_hsmi=278988838&_hsenc=p2ANqtz-_u2Yk8-AZ-WsGfoyShvBPKiXhkgwa5dL-dsEy32tjW49PqdL5lZ0kIxHrDzEpMgeLMe9z0ahAFjhKi4gN9QgWJXd6wJQ&utm_content=278988838&utm_source=hs_email